BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36402360)

  • 1. International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire.
    Sodergren SC; Johnson CD; Gilbert A; Darlington AS; Cocks K; Guren MG; Rivin Del Campo E; Brannan C; Christensen P; Chu W; Chung H; Dennis K; Desideri I; Gilbert DC; Glynne-Jones R; Jefford M; Johansson M; Johnsson A; Juul T; Kardamakis D; Lai-Kwon J; McFarlane V; Miguel IMC; Nugent K; Peters F; Riechelmann RP; Turhal NS; Wong S; Vassiliou V;
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1155-1164. PubMed ID: 36402360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.
    Sodergren SC; Johnson CD; Gilbert A; Tomaszewski KA; Chu W; Chung HT; Dennis K; Desideri I; Glynne-Jones R; Grønlie Guren M; Kardamakis D; Nugent K; Schmidt H; Sebag-Montefiore D; Vassiliou V;
    Radiother Oncol; 2018 Feb; 126(2):222-228. PubMed ID: 29217122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
    Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22).
    Greimel E; Nagele E; Lanceley A; Oberguggenberger AS; Nordin A; Kuljanic K; Arraras JI; Wei-Chu C; Jensen PT; Tomaszewski KA; Creutzberg CL; Galalae R; Toelen H; Zimmermann K; Bjelic-Radisic V; Costantini A; Almont T; Serpentini S; Paskeviciute Frøding L; Vistad I; Schmalz C;
    Eur J Cancer; 2021 Sep; 154():235-245. PubMed ID: 34298374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large scale prospective clinical and psychometric validation of the EORTC colorectal (QLQ-CR29) module in Polish patients with colorectal cancer.
    Sanna B; Bereza K; Paradowska D; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Golec J; Bottomley A; Tomaszewski KA
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28497549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
    Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH
    Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
    Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
    Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric Validation of the Bahasa Malaysia Version of the EORTC QLQ-CR29.
    Magaji BA; Moy FM; Roslani AC; Law CW; Raduan F; Sagap I
    Asian Pac J Cancer Prev; 2015; 16(18):8101-5. PubMed ID: 26745045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
    Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
    Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.
    Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB
    Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer.
    Lin JB; Zhang L; Wu DW; Xi ZH; Wang XJ; Lin YS; Fujiwara W; Tian JR; Wang M; Peng P; Guo A; Yang Z; Luo L; Jiang LY; Li QQ; Zhang XY; Zhang YF; Xu HW; Yang B; Li XL; Lei YX
    World J Gastroenterol; 2017 Mar; 23(10):1891-1898. PubMed ID: 28348496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
    Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Trinquart L; Chiang C;
    Hepatology; 2012 Apr; 55(4):1122-9. PubMed ID: 22105642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric Validation of the Malaysian Chinese Version of the EORTC QLQ-C30 in Colorectal Cancer Patients.
    Magaji BA; Moy FM; Roslani AC; Law CW; Sagap I
    Asian Pac J Cancer Prev; 2015; 16(18):8107-12. PubMed ID: 26745046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction.
    Winters ZE; Afzal M; Rutherford C; Holzner B; Rumpold G; da Costa Vieira RA; Hartup S; Flitcroft K; Bjelic-Radisic V; Oberguggenberger A; Panouilleres M; Mani M; Catanuto G; Douek M; Kokan J; Sinai P; King MT;
    Br J Surg; 2018 Feb; 105(3):209-222. PubMed ID: 29116657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
    Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
    Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.
    Whistance RN; Conroy T; Chie W; Costantini A; Sezer O; Koller M; Johnson CD; Pilkington SA; Arraras J; Ben-Josef E; Pullyblank AM; Fayers P; Blazeby JM;
    Eur J Cancer; 2009 Nov; 45(17):3017-26. PubMed ID: 19765978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Phase IV Field Study for the Reliability and Validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34.
    Singer S; Al-Ibraheem A; Pinto M; Iakovou I; Østhus AA; Hammerlid E; Locati LD; Gamper E; Ignacio J; Jordan SJ; Kiyota N; Buettner M; Engesser D; Canotilho R; Ioannidis G; Husson O; Gama RR; Fanetti G; Moss L; Inhestern J; Andry G; Fuehrer D; Kuliś D; Rimmele H; Sykiotis G
    Thyroid; 2023 Sep; 33(9):1078-1089. PubMed ID: 37450344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.